SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
INVR - Innovir Labs - On it's way back.
An SI Board Since October 1996
Posts SubjectMarks Bans Symbol
65 2 0 INVR
Emcee:  Rob C. Type:  Unmoderated
Introduction Market Data Compact
This company has 4 to 5 dollars written all over it. The investment house that was supporting the stock went out of business and we were left holding the bag. I bought back in at 7/8. The company has plenty of cash and has been on the verge of a break-thru in RNA research for CFS cure.

Check this out...
Innovir (NASDAQ:INVR) is a biotechnology company developing a broad enabling technology known as External Guide Sequences (EGSs) that has the potential to be applied as a therapeutic in the areas of viral, genetic and metabolic diseases, cancer and bacterial infections. EGSs are compounds that have been designed to target specific sease-causing mRNAs,resulting in their cleavage and inactivation by RNase P, a ribozyme found in all living cells. The EGS complex acts as a "decoy"
to redirect RNase P to cleave the target RNA before it can create disease-causing proteins. The majority of available human therapeutics target protein molecules rather than RNA.

EGS technology is based upon Nobel-Prize winning research by Dr. Sidney Altman of Yale University. Innovir has received an exclusive worldwide license from Yale to develop this patented technology for new therapeutics. The Company is pursuing hepatitis B and acute promyelocytic leukemia (APL) as initial disease targets. Both have shown positive response to EGSs in vitro, suggesting proof of principle for the therapeutic potential of the technology. In addition, Innovir has entered into collaborations with The Rockefeller University to explore the use of EGS for diseases such as psoriasis and with the University of Pennsylvania to evaluate the use of EGS technology to inhibit plant gene expression.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
65 This Company really has a future. This is a Great milestone in the recovery of PAUL D.-3/27/1998
64 Innovir Announces New FRS, -Functional Ribozyme Selection- Technology TechnologGREATMOOD-3/27/1998
63 Pretty good jump in price and vol Friday. Yahoo messages have rumor of buy-out:bob jaremsek-2/28/1998
62 Can anyone tell me the status ot the B warrants (INVRZ). They have not traded sJAMES LEE BLAND-1/13/1998
61 hhmmm..... no wonder the price got so low...... :-) rhondaR Hamilton-1/12/1998
60 To All: Innovir Laboratories Announces $7 Million Funding Agreement with VIMRX GREATMOOD-1/12/1998
59 looks great.........when do we get that major pharm. alliance???? wake me up iR Hamilton-12/17/1997
58 To All: Innovir Laboratories Receives Additional Patent Rights For Oligozymes IGREATMOOD-12/17/1997
57 Anyone still holding??? NEW YORK--(BUSINESS WIRE)--Nov. 17, 1997-- Management CRob C.-11/25/1997
56 NEW YORK--(BUSINESS WIRE)--Sept. 26, 1997-- Allan R. Goldberg, Ph.D. ResignsR Hamilton-9/26/1997
55 I don't know how this will be perceived.... NEW YORK--(BUSINESS WIRE)--AugRob C.-8/14/1997
54 if you follow invr, be sure to check us out over on the vmrx board! rhondaR Hamilton-8/6/1997
53 This is great news. I saw it first on a news website and I knew I had to get abCJ Owen Critchley-8/6/1997
52 We have arrived..... Yale Scientists Successfully Use Technology Licensed By IRob C.-8/5/1997
51 Hats off to all the faithful INVR holders. TomTom Shutters-8/4/1997
50 INVR will go Tues-anyone know exercise price et al on invrw?songw-8/4/1997
49 Anyone out there??? Recent filing says they are doubling shares outstanding???Rob C.-7/2/1997
48 HEAVY volume this morning with a BUY side bias so far. Could this be in anticipdan oreilly-6/16/1997
47 INVR has been very stong and there has been renewed activity in the warrants siJ Walter Jacobs-6/13/1997
46 Hi Robert. I'm just looking at this stock. Are they doing any phase 1,2,or3Tom Hofmann-6/13/1997
45 Yeah, I sold the last of my INVR portfolio the other day at 3/4. It will mostSkiawal-4/3/1997
44 Great volume today and we tested 1 3/8's.....any news, announcements, rumorRob C.-4/3/1997
43 VIMRx announces fourth quarter and full year 1996 results WILMINGTON, DEL. (MRob C.-3/31/1997
42 Why is INVR drifting lower again??? Would love to know what is going on??? NewRob C.-3/31/1997
41 There are two warrants, both expire 8/12/98. INVRW lets you buy one common shaForbes Little-3/18/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News